Retraction
Erlotinib, an effective epidermal growth factor receptor tyrosine kinase inhibitor, induces p27KIP1 up-regulation and nuclear translocation in association with cell growth inhibition and G1/S phase arrest in human non-small-cell lung cancer cell lines
Paper Information
Record ID:
3942
Journal:
Publication Date:
July 24, 2007
Retraction Date:
June 30, 2015
(10.4 years years ago)
Subjects:
Institution:
Department of Oncology, Department of Molecular Genetics, Albert Einstein College of Medicine, Bronx, New YorkCountry:
🇺🇸 United StatesArticle Type:
Publisher:
ASPET: American Society for Pharmacology and Experimental Therapeutics
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Citations (70)
70
Total Citations15
Post-Retraction(21.4%)
48
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
3
Within 1 year
9
After 2+ years
3396
Days since retraction (latest)
Paper citing Erlotinib, an effective epidermal growth factor re...
Unknown Authors
Unknown Journal
Published: Apr 2010
1898 days before retraction
Paper citing Erlotinib, an effective epidermal growth factor re...
Unknown Authors
Unknown Journal
Published: Mar 2010
1918 days before retraction
Paper citing Erlotinib, an effective epidermal growth factor re...
Unknown Authors
Unknown Journal
Published: Mar 2010
1947 days before retraction
Paper citing Erlotinib, an effective epidermal growth factor re...
Unknown Authors
Unknown Journal
Published: Dec 2009
2036 days before retraction
Paper citing Erlotinib, an effective epidermal growth factor re...
Unknown Authors
Unknown Journal
Published: Dec 2009
2037 days before retraction
Paper citing Erlotinib, an effective epidermal growth factor re...
Unknown Authors
Unknown Journal
Published: Jul 2009
2190 days before retraction
Paper citing Erlotinib, an effective epidermal growth factor re...
Unknown Authors
Unknown Journal
Published: Jun 2009
2204 days before retraction
Paper citing Erlotinib, an effective epidermal growth factor re...
Unknown Authors
Unknown Journal
Published: Jun 2009
2220 days before retraction
Paper citing Erlotinib, an effective epidermal growth factor re...
Unknown Authors
Unknown Journal
Published: Jun 2009
2220 days before retraction
Paper citing Erlotinib, an effective epidermal growth factor re...
Unknown Authors
Unknown Journal
Published: May 2009
2251 days before retraction
Paper citing Erlotinib, an effective epidermal growth factor re...
Unknown Authors
Unknown Journal
Published: Apr 2009
2281 days before retraction
Paper citing Erlotinib, an effective epidermal growth factor re...
Unknown Authors
Unknown Journal
Published: Feb 2009
2340 days before retraction
Paper citing Erlotinib, an effective epidermal growth factor re...
Unknown Authors
Unknown Journal
Published: Nov 2008
2432 days before retraction
Paper citing Oncogenic role of the ubiquitin ligase subunit Skp...
Unknown Authors
Unknown Journal
Published: Oct 2008
2434 days before retraction
Paper citing Erlotinib, an effective epidermal growth factor re...
Unknown Authors
Unknown Journal
Published: Jun 2008
2582 days before retraction
Paper citing Erlotinib, an effective epidermal growth factor re...
Unknown Authors
Unknown Journal
Published: May 2008
2590 days before retraction
Paper citing Erlotinib, an effective epidermal growth factor re...
Unknown Authors
Unknown Journal
Published: May 2008
2616 days before retraction
Paper citing Erlotinib, an effective epidermal growth factor re...
Unknown Authors
Unknown Journal
Published: Feb 2008
2706 days before retraction
Paper citing Erlotinib, an effective epidermal growth factor re...
Unknown Authors
Unknown Journal
Published: Feb 2008
2706 days before retraction
Paper citing Erlotinib, an effective epidermal growth factor re...
Unknown Authors
Unknown Journal
Published: Nov 2007
2798 days before retraction
Quick Stats
Total Citations:
70
Years Since Retraction:
10.4 years
Open Access:
Yes
Last Checked:
Never